The Development Course of Sanjiu Pharmaceutical Co., Ltd.

Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") is a joint stock limited company registered in People's Republic of China (PRC). Approved by the former State Economic and Trade Management Committee and State Economic and Trade Enterprise Reform [1999]No. 134 on March 2, 2009, Shenzhen Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as Sanjiu Pharmaceutical), Shenzhen Jiuxian Bioengineering Co., Ltd. (hereinafter referred to as Jiuxian Bioengineering).

On May 22nd, 2008, with the approval of Shenzhen Administration for Industry and Commerce, our company renewed the Business License of Enterprise as a Legal Person with the registration number of 440301kloc-0/03302647. The RMB common stock A shares issued by the company have been listed on Shenzhen Stock Exchange. The company is headquartered in Yinhu Road, Luohu District, Shenzhen City, Guangdong Province.

When the company was established, the original registered capital was RMB 553 million and the total share capital was 553 million shares.

With the approval of China Securities Regulatory Commission, the company issued 200,000 RMB ordinary shares 1999 1 42 to the public in June.

On March 9, 2000, it was officially listed and traded in Shenzhen Stock Exchange, with its registered capital increased to 753 million yuan and total share capital of 753 million shares, of which 552 million shares were held by state-owned promoters, 65.438 million shares were held by domestic legal persons and 200 million shares were held by the public. The par value of the company's shares is RMB 65,438+0 yuan.

According to the resolution of the second general meeting of shareholders in 2003, based on the share capital of 65,438+February 3 1 day of 753 million shares, the capital reserve was increased to 225.9 million shares (par value per share 1 yuan) and 3 shares were increased. After the transfer, the registered capital of the company increased to RMB 978.9 million, but the industrial and commercial change procedures for capital increase have not been completed.

As of June 65438+February 3, 20081day, the company issued 978.9 million shares.

On April 6, 2008, according to the Reply of the State Council State-owned Assets Supervision and Administration Commission [2008] No.384 on Issues Concerning the Changes of State-owned Shareholders' Rights and Interests of Sanjiu Pharmaceutical Co., Ltd., Sanjiu Group held 84,462,520 shares of state-owned legal person shares, and Sanjiu Pharmaceutical held 613,937,480 shares of state-owned legal person shares.

On June 16, 2008, the Ministry of Commerce approved the above-mentioned equity change with the document number. [2008] No.602 Reply of the Ministry of Commerce on Agreeing to the Equity Transfer of Sanjiu Pharmaceutical Co., Ltd.

As of June 5438+February 3, 20081day, except for 42,065,438+09,587 shares held by Sanjiu Group, all other shares involved in the transfer have been confirmed by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch and transferred to XinSanjiu Holdings. The company officially entered China Resources Group at the end of June 2007.

On February 20 10, the name of the company was officially changed from "Sanjiu Pharmaceutical Co., Ltd." to China Resources Sanjiu Pharmaceutical Co., Ltd. after being audited by the State Administration for Industry and Commerce and approved by the Shenzhen Municipal Market Supervision Administration.